Diabetes Care, Vol 22, Issue 2 280-287, Copyright © 1999 by American Diabetes Association

ARTICLES

alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes

T Konrad, P Vicini, K Kusterer, A Hoflich, A Assadkhani, HJ Bohles, A Sewell, HJ Tritschler, C Cobelli and KH Usadel
Department of Internal Medicine, J.W. Goethe-University, Frankfurt, Germany.

OBJECTIVE: We examined the effect of lipoic acid (LA), a cofactor of the pyruvate dehydrogenase complex (PDH), on insulin sensitivity (SI) and glucose effectiveness (SG) and on serum lactate and pyruvate levels after oral glucose tolerance tests (OGTTs) and modified frequently sampled intravenous glucose tolerance tests (FSIGTTs) in lean (n = 10) and obese (n = 10) patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: FSIGTT data were analyzed by minimal modeling technique to determine SI and SG before and after oral treatment (600 mg, twice a day, for 4 weeks). Serum lactate and pyruvate levels of diabetic patients after glucose loading were compared with those of lean (n = 10) and obese (n = 10) healthy control subjects in which SI and SG were also determined from FSIGTT data. RESULTS: Fasting lactate and pyruvate levels were significantly increased in patients with type 2 diabetes. These metabolites did not exceed elevated fasting concentrations after glucose loading in lean patients with type 2 diabetes. However, a twofold increase of lactate and pyruvate levels was measured in obese diabetic patients. LA treatment was associated with increased SG in both diabetic groups (lean 1.28 +/- 0.14 to 1.93 +/- 0.13; obese 1.07 +/- 0.11 to 1.53 +/- 0.08 x 10(-2) min-1, P < 0.05). Higher SI and lower fasting glucose were measured in lean diabetic patients only (P < 0.05). Lactate and pyruvate before and after glucose loading were approximately 45% lower in lean and obese diabetic patients after LA treatment. CONCLUSIONS: Treatment of lean and obese diabetic patients with LA prevents hyperglycemia-induced increments of serum lactate and pyruvate levels and increases SG.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. W. Milgram, J. A. Araujo, T. M. Hagen, B. V. Treadwell, and B. N. Ames Acetyl-L-carnitine and {alpha}-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests FASEB J, November 1, 2007; 21(13): 3756 - 3762. [Abstract] [Full Text] [PDF]

				M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]

				X. Yi and N. Maeda {alpha}-Lipoic Acid Prevents the Increase in Atherosclerosis Induced by Diabetes in Apolipoprotein E-Deficient Mice Fed High-Fat/Low-Cholesterol Diet. Diabetes, August 1, 2006; 55(8): 2238 - 2244. [Abstract] [Full Text] [PDF]

				A. Pfutzner, T. Kunt, C. Hohberg, A. Mondok, S. Pahler, T. Konrad, G. Lubben, and T. Forst Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes Diabetes Care, March 1, 2004; 27(3): 682 - 687. [Abstract] [Full Text] [PDF]

				G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]

				N. Dicter, Z. Madar, and O. Tirosh {alpha}-Lipoic Acid Inhibits Glycogen Synthesis in Rat Soleus Muscle via Its Oxidative Activity and the Uncoupling of Mitochondria J. Nutr., October 1, 2002; 132(10): 3001 - 3006. [Abstract] [Full Text] [PDF]

				V. Saengsirisuwan, F. R. Perez, T. R. Kinnick, and E. J. Henriksen Effects of exercise training and antioxidant R-ALA on glucose transport in insulin-sensitive rat skeletal muscle J Appl Physiol, January 1, 2002; 92(1): 50 - 58. [Abstract] [Full Text] [PDF]

				M. F. Melhem, P. A. Craven, J. Liachenko, and F. R. DeRubertis {alpha}-Lipoic Acid Attenuates Hyperglycemia and Prevents Glomerular Mesangial Matrix Expansion in Diabetes J. Am. Soc. Nephrol., January 1, 2002; 13(1): 108 - 116. [Abstract] [Full Text] [PDF]

				V. Saengsirisuwan, T. R. Kinnick, M. B. Schmit, and E. J. Henriksen Interactions of exercise training and lipoic acid on skeletal muscle glucose transport in obese Zucker rats J Appl Physiol, July 1, 2001; 91(1): 145 - 153. [Abstract] [Full Text] [PDF]

				D. Konrad, R. Somwar, G. Sweeney, K. Yaworsky, M. Hayashi, T. Ramlal, and A. Klip The Antihyperglycemic Drug {alpha}-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation: Potential Role of p38 Mitogen-Activated Protein Kinase in GLUT4 Activation Diabetes, June 1, 2001; 50(6): 1464 - 1471. [Abstract] [Full Text]

				B. A. Maddux, W. See, J. C. Lawrence Jr., A. L. Goldfine, I. D. Goldfine, and J. L. Evans Protection Against Oxidative Stress--Induced Insulin Resistance in Rat L6 Muscle Cells by Micromolar Concentrations of {alpha}-Lipoic Acid Diabetes, February 1, 2001; 50(2): 404 - 410. [Abstract] [Full Text]

				J. A. Peth, T. R. Kinnick, E. B. Youngblood, H. J. Tritschler, and E. J. Henriksen Effects of a unique conjugate of alpha -lipoic acid and gamma -linolenic acid on insulin action in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R453 - R459. [Abstract] [Full Text] [PDF]